News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Guided Therapeutics, Inc. Enters into Preliminary Research Agreement with Konica Minolta Opto, Inc. in Anticipation of Asian Distribution; Plan to Initiate Screening Trials for LuViva Advanced Cervical Scan


7/20/2011 9:34:55 AM

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP), developer of a rapid and painless biophotonic testing platform for the early detection of cancer, today announced that it has entered into a preliminary agreement with Konica Minolta Opto, Inc. of Tokyo, to conduct clinical and market research for the LuViva™ Advanced Cervical Scan product in certain Asian markets. As part of the agreement, the two companies also plan to conduct a clinical trial to establish screening claims for LuViva, as a method to replace the Pap test for early cervical disease detection in international markets.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES